March 08 Editorial List
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued
A precautionary recall of Zaditen eye drops is issued due to potential microbial contamination, affecting batch 4V64. No adverse events reported.
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Breye Therapeutics completes phase 1B trial of danegaptide oral therapy for diabetic retinopathy
Investigators reported the oral therapy was well-tolerated in trials for early treatment of non-proliferative diabetic retinopathy and associated oedema
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Long-duration spaceflight tests the limits of telemedicine
In-orbit imaging drives innovation in terrestrial telemedicine, the NASA scientist explained
Interdisciplinary report illuminates demographic, systemic health factors of dry eye disease
Remaining questions about DED pertain to geographic considerations, prevalence measures for DED in children and the design of future studies to determine risk factors in patients under 40